GlassScriptPhysician profile
Matthew A Bernabei
NPI 1821056771
$52,191.93
in general payments reported to CMS, 2019-2025
11 companies · $15K in 2025
The $15K reported for 2025 was more than what 86% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,319 · 2020: $7,380 · 2021: $9,120 · 2022: $977 · 2023: $6,387 · 2024: $11K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $24K · Travel and Lodging: $3,415 · Food and Beverage: $2,894 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $24,287.50 |
| Travel and Lodging | $3,415.07 |
| Food and Beverage | $2,894.45 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $33,919.33 | 2019-2025 | Accent, Aveir, Tendril |
| Medtronic, INC. | $8,472.32 | 2021-2025 | Selectsecure, Affera Mapping System, Azure Xt Dr Mri Surescan |
| Medtronic Vascular, INC. | $6,439.00 | 2020 | |
| Boston Scientific Corporation | $2,165.53 | 2019-2025 | Watchman Flx, Farapulse, Watchman Access System |
| Medical Device Business Services, INC. | $704.88 | 2019 | |
| Biosense Webster, INC. | $296.21 | 2019-2023 | Carto 3 |
| Biotronik INC. | $116.34 | 2023 | Biomonitor, Acticor 7 Vr-T Dx |
| Acutus Medical, INC. | $59.06 | 2021 | |
| Abiomed | $19.26 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Bernabei listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.